1. Home
  2. SCL vs CTMX Comparison

SCL vs CTMX Comparison

Compare SCL & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stepan Company

SCL

Stepan Company

HOLD

Current Price

$51.70

Market Cap

1.1B

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.18

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCL
CTMX
Founded
1932
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
977.1M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
SCL
CTMX
Price
$51.70
$4.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$75.00
$12.10
AVG Volume (30 Days)
119.9K
10.8M
Earning Date
04-28-2026
05-11-2026
Dividend Yield
3.20%
N/A
EPS Growth
N/A
N/A
EPS
2.05
N/A
Revenue
$1,803,737,000.00
$76,201,000.00
Revenue This Year
$6.60
N/A
Revenue Next Year
$5.27
$18.75
P/E Ratio
$24.11
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$41.82
$0.48
52 Week High
$68.00
$8.21

Technical Indicators

Market Signals
Indicator
SCL
CTMX
Relative Strength Index (RSI) 58.06 42.66
Support Level $47.21 $3.89
Resistance Level $52.57 $4.54
Average True Range (ATR) 1.32 0.34
MACD 0.65 -0.01
Stochastic Oscillator 99.61 14.49

Price Performance

Historical Comparison
SCL
CTMX

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: